Cel Sci Corporation (CVM)

[GD]

I keep coming back to NWBO as an example, if MK data is barely
positive with many conflicting subgroup data, it is not hard to
think Geert may follow NWBO's model of looking for KOL's support
and validation first and PR the data after, keep in mind CVM
and NWBO CEO are lawyers, they are not normal small biotech
CEOs, I jus think they over estimate their power to over come
Wallstreet and BP forces if the data is weak like DNDN, IMO.
By the way, I still think Fosco's estimate 23% OSI is believable
and after Geert get the data report, he may PR in days. My issue
is if Geert holds the data PR for up to 6 weeks after he receives it,
it sure indicates weak data to me.